CAPPELLINI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 1.947
NA - Nord America 1.734
AS - Asia 862
SA - Sud America 60
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 10
OC - Oceania 6
Totale 4.633
Nazione #
US - Stati Uniti d'America 1.714
IE - Irlanda 530
CN - Cina 361
SE - Svezia 357
DE - Germania 259
UA - Ucraina 237
RU - Federazione Russa 202
SG - Singapore 183
IT - Italia 164
TR - Turchia 157
HK - Hong Kong 84
FI - Finlandia 69
GB - Regno Unito 60
BR - Brasile 53
VN - Vietnam 34
IN - India 21
BE - Belgio 20
EU - Europa 13
FR - Francia 13
PL - Polonia 11
CA - Canada 10
MX - Messico 8
AT - Austria 7
NL - Olanda 6
AU - Australia 5
ZA - Sudafrica 5
IQ - Iraq 4
JP - Giappone 4
EC - Ecuador 3
MA - Marocco 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KZ - Kazakistan 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
AL - Albania 1
AR - Argentina 1
ES - Italia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.633
Città #
Dublin 530
Chandler 366
Jacksonville 181
Izmir 150
Rome 93
Boardman 89
Hong Kong 84
Ann Arbor 79
Wilmington 77
Dallas 73
Nanjing 73
The Dalles 69
Singapore 66
Woodbridge 62
Beijing 51
Ashburn 47
Hefei 47
Lawrence 46
Princeton 46
Brooklyn 44
Moscow 38
Ogden 29
Nanchang 28
New York 28
Brandenburg 25
Bologna 23
Helsinki 23
Brussels 20
Dearborn 19
Los Angeles 18
Munich 17
Changsha 16
Dong Ket 16
Milan 15
Des Moines 14
Inglewood 14
San Francisco 14
Jiaxing 13
Orange 13
Santa Clara 13
Hebei 12
Kunming 12
Tianjin 12
Falls Church 11
Seattle 9
Shenyang 9
Warsaw 9
Cassino 8
Ho Chi Minh City 8
São Paulo 8
Verona 8
Lanzhou 7
Salerno 7
Fairfield 6
Hangzhou 6
Hanoi 6
Pune 6
Haikou 5
Manchester 5
Montreal 5
Nuremberg 5
Chennai 4
London 4
Ningbo 4
Tokyo 4
Turku 4
Vienna 4
Amsterdam 3
Boston 3
Changchun 3
Chicago 3
Hanover 3
Norwalk 3
Tappahannock 3
Toronto 3
Zhengzhou 3
Ankara 2
Atlanta 2
Auburn Hills 2
Baghdad 2
Cambridge 2
Canberra 2
Clifton 2
Frankfurt am Main 2
Houston 2
Jinan 2
Johannesburg 2
Katowice 2
Kocaeli 2
Luxembourg 2
Melbourne 2
Mumbai 2
Olomouc 2
Porto Alegre 2
Redwood City 2
Saint Petersburg 2
St Petersburg 2
Stockholm 2
São José do Rio Preto 2
Vitória 2
Totale 2.932
Nome #
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling 176
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. 151
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. 144
Caspase-dependent cleavage of 170-kDa P-glycoprotein during apoptosis of human T-lymphoblastoid CEM cells. 131
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers. 130
Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes 123
Two hits are better than one: targeting both phosphatidylinositol3-kinase and mammalian target of rapamycin as a therapeuticstrategy for acute leukemia treatment 115
Detection of serine 473 phosphorylated Akt in acute myeloid leukaemia blasts by flow cytometry 113
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells 112
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB 112
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway 110
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 108
Metabolism and signaling activities of nuclear lipids. 108
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand 108
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. 107
PI3K paninhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors 107
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 107
Supravital exposure to propidium iodide identifies apoptosis on adherent cells. 106
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 103
Flow cytometric detection of total and serine 473 phosphorylated Akt. 103
Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts. 103
The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. 102
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 101
Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. 101
Antiapoptotic role of p38 mitogen activated protein kinase in Jurkat T cells and normal human T lymphocytes treated with 8-methoxypsoralen and ultraviolet-A radiation. 100
Molecular characterization of protein kinase C-alpha binding to lamin A. 100
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 98
Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells 97
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting 97
Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? 97
Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts. 95
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 95
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 95
Targeting the liver kinaseB1/AMP-activated protein kinasepathway as a therapeutic strategyfor hematological malignancies 94
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 94
Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway 94
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. 94
The controversial nuclear matrix: a balanced point of view. 93
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia 92
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 92
Enhancing radiosensitivity of melanoma cells through very high dose rate pulses released by a plasma focus device. 91
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. 89
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia. 84
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs) 72
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) 68
Therapeutic targeting of CK2 in acute and chronic leukemias 65
Totale 4.777
Categoria #
all - tutte 23.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 1 54 5 47 1 53 9 68
2021/2022345 7 4 1 26 35 9 7 34 10 17 69 126
2022/20231.568 103 145 57 154 87 261 0 93 622 5 17 24
2023/2024207 24 16 19 3 6 13 26 16 58 4 2 20
2024/2025662 24 12 44 9 54 10 72 59 235 6 68 69
2025/2026418 77 222 58 49 12 0 0 0 0 0 0 0
Totale 4.777